Novartis is one of those companies that politicians and policymakers like to talk so much about. It makes real things. It employs real people. It pays real tax. The Swiss drugmaker has in the region of 700 Irish staff, ranging from high-level management to general administration workers. Accounts for its main Irish subsidiary, Novartis Ireland Limited, show it received revenues in 2019 of €221 million and made a pre-tax profit of €6.5 million. It made this money by supplying pharmaceutical products to the healthcare sector and providing business services to group and subsidiary companies. On any metric, the business is…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .